Pharmaceutical Research · 2020 · 52 citations · 63 references
Life SciencesMolecular BiologyOncologyDrug DeliveryNanobiotechnologyNanoparticle Drug DeliveryCancer NanomedicineCell-nanoparticle InteractionsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignCancer NanotherapyChitosan NanocarriersChitosan-based NanomaterialsHif-1 SignalingTumor-targeted Drug Delivery
63
Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
David Parry, Timothy J. Guzi, Nicole R. Davis et al. · Molecular Cancer Therapeutics · 2010 · 561 citations · Full text
Medicine, Oncology, Pharmacology +17
Tobias Lammel, Paul Boisseaux, María Luisa Fernández‐Cruz et al. · Particle and Fibre Toxicology · 2013 · 395 citations · Full text